Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Legend Biotech Corporation LEGN

Full chart Compare
Set alert

Price alert · LEGN

All alert types
22.77 USD +1.29 (+6.01%)

At closeNov 4, 2026, 4:01 PM EST

22.77 0.00 0.00%

After hours · Nov 4, 4:01 PM ET

21.70 Day range 23.71
16.24 52-week range 37.50
YTD
+4.74%
1 year
-28.95%

Financial health

Altman Z-Score

4.54 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -13.6×
FY 2017: 522×FY 2018: -1331×FY 2019: -36.6×FY 2020: -11.0×FY 2021: -17.0×FY 2022: -17.8×FY 2023: -20.5×FY 2024: -33.5×FY 2025: -13.6×
FY 2017 5y median -17.8× FY 2025
P/S 3.9×
FY 2017: 207×FY 2018: 75.3×FY 2019: 79.0×FY 2020: 44.4×FY 2021: 95.4×FY 2022: 67.9×FY 2023: 37.2×FY 2024: 9.5×FY 2025: 3.9×
FY 2017 5y median 37.2× FY 2025
P/B 4.0×
FY 2017: 401×FY 2018: 428×FY 2019: -39.8×FY 2020: 5.6×FY 2021: 8.6×FY 2022: 10.7×FY 2023: 8.5×FY 2024: 5.7×FY 2025: 4.0×
FY 2017 5y median 8.5× FY 2025
P/FCF -23.8×
FY 2017: -1497×FY 2018: 12.9×FY 2019: -40.0×FY 2020: -13.1×FY 2021: -26.9×FY 2022: -35.5×FY 2023: -25.5×FY 2024: -37.6×FY 2025: -23.8×
FY 2017 5y median -26.9× FY 2025
EV/EBITDA -15.1×
FY 2017: 347×FY 2018: 23451×FY 2019: -37.8×FY 2020: -9.6×FY 2021: -15.3×FY 2022: -17.9×FY 2023: -20.2×FY 2024: -53.1×FY 2025: -15.1×
FY 2017 5y median -17.9× FY 2025
EV/Sales 3.4×
FY 2017: 207×FY 2018: 71.1×FY 2019: 77.8×FY 2020: 38.3×FY 2021: 87.2×FY 2022: 63.6×FY 2023: 33.8×FY 2024: 9.6×FY 2025: 3.4×
FY 2017 5y median 33.8× FY 2025
FCF Yield -4.2%
FY 2017: -0.1%FY 2018: 7.7%FY 2019: -2.5%FY 2020: -7.6%FY 2021: -3.7%FY 2022: -2.8%FY 2023: -3.9%FY 2024: -2.7%FY 2025: -4.2%
FY 2017 5y median -3.7% FY 2025

Profitability

Gross Margin 60.3%
FY 2017: 100.4%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 44.1%FY 2023: 49.4%FY 2024: 62.6%FY 2025: 60.3%
FY 2017 5y median 60.3% FY 2025
Operating Margin -13.3%
FY 2017: 58.4%FY 2018: -3.1%FY 2019: -214.4%FY 2020: 0.0%FY 2021: -570.0%FY 2022: -389.4%FY 2023: -154.1%FY 2024: -48.3%FY 2025: -13.3%
FY 2017 5y median -154.1% FY 2025
Net Margin -28.8%
FY 2017: 39.7%FY 2018: -5.7%FY 2019: -164.4%FY 2020: -355.2%FY 2021: -586.4%FY 2022: -381.5%FY 2023: -181.8%FY 2024: -28.2%FY 2025: -28.8%
FY 2017 5y median -181.8% FY 2025
ROE -29.6%
FY 2017: 77.0%FY 2018: -32.2%FY 2019: 82.7%FY 2020: -44.6%FY 2021: -52.7%FY 2022: -60.0%FY 2023: -41.4%FY 2024: -17.0%FY 2025: -29.6%
FY 2017 5y median -41.4% FY 2025
ROIC -9.6%
FY 2017: 5.0%FY 2018: -0.6%FY 2019: -65.7%FY 2020: 0.0%FY 2021: -43.6%FY 2022: -43.9%FY 2023: -26.8%FY 2024: -21.7%FY 2025: -9.6%
FY 2017 5y median -26.8% FY 2025
ROA -17.1%
FY 2017: 3.9%FY 2018: -0.6%FY 2019: -35.3%FY 2020: -36.9%FY 2021: -36.1%FY 2022: -33.5%FY 2023: -28.0%FY 2024: -10.6%FY 2025: -17.1%
FY 2017 5y median -28.0% FY 2025

Growth (YoY)

Revenue 64.0%
FY 2017: 0.0%FY 2018: 108.2%FY 2019: 25.8%FY 2020: 21.4%FY 2021: -8.2%FY 2022: 70.0%FY 2023: 143.7%FY 2024: 120.0%FY 2025: 64.0%
FY 2017 FY 2025
Operating Income 55.0%
FY 2017: 0.0%FY 2018: -111.1%FY 2019: -8538.5%FY 2020: 100.0%FY 2021: 0.0%FY 2022: -16.1%FY 2023: 3.5%FY 2024: 31.0%FY 2025: 55.0%
FY 2017 FY 2025
EPS (diluted) -64.9%
FY 2017: 0.0%FY 2018: -139.2%FY 2019: -3533.1%FY 2020: -154.5%FY 2021: -6.6%FY 2022: -2.6%FY 2023: -4.6%FY 2024: 67.0%FY 2025: -64.9%
FY 2017 FY 2025
Free Cash Flow -6.3%
FY 2017: 0.0%FY 2018: 8885.2%FY 2019: -142.6%FY 2020: -107.2%FY 2021: 3.7%FY 2022: 8.3%FY 2023: -86.1%FY 2024: 62.0%FY 2025: -6.3%
FY 2017 FY 2025

Financial Health

Current Ratio 2.0×
FY 2017: 4.4×FY 2018: 2.1×FY 2019: 1.6×FY 2020: 5.1×FY 2021: 4.1×FY 2022: 3.7×FY 2023: 6.9×FY 2024: 4.6×FY 2025: 2.0×
FY 2017 5y median 4.1× FY 2025
Quick Ratio 1.9×
FY 2017: 4.4×FY 2018: 2.0×FY 2019: 1.6×FY 2020: 5.1×FY 2021: 4.1×FY 2022: 3.7×FY 2023: 6.8×FY 2024: 4.5×FY 2025: 1.9×
FY 2017 5y median 4.1× FY 2025
Debt / Equity 0.4×
FY 2017: 0.0×FY 2018: 0.5×FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.4×
FY 2017 5y median 0.3× FY 2025
Net Debt / EBITDA 2.1×
FY 2017: -0.1×FY 2018: -1382×FY 2019: 0.6×FY 2020: 1.5×FY 2021: 1.4×FY 2022: 1.2×FY 2023: 2.0×FY 2024: -0.6×FY 2025: 2.1×
FY 2017 5y median 1.4× FY 2025
Interest Coverage -6.4×
FY 2017: 0.0×FY 2018: -18.7×FY 2019: -594×FY 2020: 0.0×FY 2021: -436×FY 2022: -42.2×FY 2023: -20.2×FY 2024: -14.0×FY 2025: -6.4×
FY 2017 5y median -20.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31